Develops gene-edited productivity traits for seed companies and bio-based fragrance ingredients for consumer-products partners.
10-K for FY2025, filed Mar 17, 2026COMPANY OVERVIEWCibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop…View ↗
- 4 - little as one year. Cibus’ primary trait business opportunities continue to broaden as key jurisdictions around the world more…View ↗
Cibus’ Secondary Program – Sustainable IngredientsAlongside its Rice program, Cibus also continues to advance its sustainable ingredients…View ↗
Research collaborators pay through upfront payments, research-cost reimbursements and milestone payments; Cibus can also earn royalties when commercialized products containing its traits are sold.
10-K for FY2025, filed Mar 17, 2026Revenue is recognized from research collaboration agreements, sales of products, from licenses of technology, and from product development…View ↗
In the future, the Company may continue to generate revenue from collaboration and research agreements, but it expects an increasing amount…View ↗
License fees, non-refundable upfront fees, and funding of research activities are considered fixed, while milestone payments are identified…View ↗
$3.6M
10-K for FY2025, filed Mar 17, 2026
$3.6M ↗
Seed companies license Cibus traits for inclusion in their seeds; research collaborators and a consumer-products partner support work on sustainable ingredients.
10-K for FY2025, filed Mar 17, 2026- 4 - little as one year. Cibus’ primary trait business opportunities continue to broaden as key jurisdictions around the world more…View ↗
Cibus’ Secondary Program – Sustainable IngredientsAlongside its Rice program, Cibus also continues to advance its sustainable ingredients…View ↗
OVERVIEW AND BUSINESS UPDATECibus is a leading agricultural biotechnology company that uses proprietary gene editing technologies to…View ↗
No. It lost $127.1M in FY2025.
10-Q for Q3 FY2026, filed Nov 12, 2026
−$21.9MView ↗
8-K, filed Jun 9, 2026
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of…View ↗
From plant-based production to trait development
The older report centered on engineering plant-based chemistries for production in a BioFactory, while describing seed traits as a secondary activity. The latest report centers on developing gene-edited productivity traits for seed companies, while continuing a sustainable-ingredients program.
10-K for FY2022, filed Mar 2, 2023 10-K for FY2025, filed Mar 17, 2026Calyxt, Inc. was founded in 2010 and incorporated in Delaware. Calyxt is a plant-based synthetic biology company. The Company leverages its…View ↗
The production of the Company’s plant-based chemistries occurs in its proprietary BioFactory production system. This strategic initiative…View ↗
The Company also out-licenses elements of the PlantSpring technology platform, has historically developed seed-trait product candidates for…View ↗
COMPANY OVERVIEWCibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop…View ↗
- 4 - little as one year. Cibus’ primary trait business opportunities continue to broaden as key jurisdictions around the world more…View ↗
Cibus’ Secondary Program – Sustainable IngredientsAlongside its Rice program, Cibus also continues to advance its sustainable ingredients…View ↗
Competes with BASF, Bayer Crop Science, Corteva AgriScience, Syngenta, Inari Agriculture, and Pairwise Plants
10-K for FY2025, filed Mar 17, 2026The market for agricultural productivity traits is highly competitive, and Cibus faces significant competition. The development of…View ↗
Loading...